Abstract

Niemann-Pick type C (NPC) is a neurodegenerative disorder characterized by progressive accumulation of cholesterol, gangliosides, and other lipids in the central nervous system and visceral organs. In the NPC1 mouse model, neurodegeneration and neuronal cell loss occur before postnatal day 21. Whether neuronal cholesterol accumulation occurs in vivo before the first signs of neuronal cell loss has not been demonstrated. In this report, we used the NPC1 mouse model and employed a novel cholesterol binding reagent, BC theta, that enabled us to visualize cellular cholesterol accumulation at a level previously unattainable. The results demonstrate the superiority of BC theta staining over conventional filipin staining in confocal microscopy and highlight several new findings. We show that at postnatal day 9, although only mild signs of neurodegeneration are detectable, significant neuronal cholesterol accumulation has already occurred throughout the NPC1 brain. In addition, although NPC1 Purkinje neurons exhibit a normal morphology at day 9, significant cholesterol accumulation within their extensive dendritic trees has occurred. We also show that in the thalamus and cortex of NPC1 mice, activated glial cells first appear at postnatal day 9 and heavily populate by day 22, suggesting that in NPC1 mice, neuronal cholesterol accumulation precedes neuronal injury and neuronal cell loss.

Highlights

  • Niemann-Pick type C (NPC) is a neurodegenerative disorder characterized by progressive accumulation of cholesterol, gangliosides, and other lipids in the central nervous system and visceral organs

  • Despite evidence at the in vitro level favoring the view that NPC1 and NPC2 are involved in intracellular cholesterol transport, the direct connection between cholesterol accumulation and neurodegeneration in NPC brains remains under debate

  • In the NPC1 mouse, neurodegeneration and low levels of neuronal cell loss have been reported to occur before postnatal day 21, with the earliest signs of neurodegeneration reported at postnatal day 9 [21, 22]

Read more

Summary

Introduction

Niemann-Pick type C (NPC) is a neurodegenerative disorder characterized by progressive accumulation of cholesterol, gangliosides, and other lipids in the central nervous system and visceral organs. We show that at postnatal day 9, only mild signs of neurodegeneration are detectable, significant neuronal cholesterol accumulation has already occurred throughout the NPC1 brain. The same group of investigators showed that treating NPC1 animals with the drug N-butyldeoxynojirimycin, an inhibitor of the enzyme glucosylceramide synthase, a key enzyme in the early glycosphingolipid biosynthesis pathway, decreased the ganglioside accumulation and the accompanying neuropathological changes in their brains [19]. These and other studies suggested that NPC1 might be considered a glycolipid storage disease rather than a cholesterol storage disease. Whether significant cholesterol accumulation occurs in vivo before the first signs of neuronal cell loss (pre-postnatal day 21) and neurodegeneration has not been demonstrated

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.